Objectives

After participating in this educational activity, attendees should be able to:

1|Define the role of basal insulin in type 2 diabetes management
2|Evaluate current literature regarding once-weekly insulin efsitora
3|Explore the application of once-weekly insulin to patient care
4|Review the current treatment options available for treatment of obesity
5|Describe the mechanism of action of maridebartcafraglutide
6|Evaluate the results of the maridebartcafraglutide phase 2 trial
7|Apply the current literature on maridebartcafraglutide to its potential use in clinical practice

 

Presenter(s): 
Madeline Fore, PharmD
PGY1 Community Based Pharmacy Resident
Baystate Medical Center
 
Ashley Roding, PharmD
PGY1 Community Based Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Madeline Fore, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Ashley Roding, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
11/03/2025 - 2:00pm to 3:00pm EST
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.